Drawing for UNVEIL-IT

USPTO serial 79416803

UNVEIL-IT

Reviewed by CopyMark Law Group

Reg. 7924240Status 700Registered
Filing date
Status date
Registration date
Sep 2, 2025
Examiner
SCHLEGELMILCH, JONATHON A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UNVEIL-IT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald M. Kachmarik

Ronald M. Kachmarik Cooper Legal Group LLC1388 Ridge Road, Unit 1Hinckley, OH 44233United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific research for medical purposes in the field of pharmaceuticals; pharmaceutical research and development services; Scientific research in the nature of conducting clinical trials to determine the efficacy and safety of pharmaceutical products in the treatment of decompensated liver disease, acute-on-chronic liver failure (ACLF); conducting scientific feasibility studies, including analysis; providing information, including results and data, relating to scientific or medical research in the field of pharmaceuticals and development of pharmaceutical products, especially from an online searchable database; Scientific research in the nature of conducting clinical trials for others; pharmaceutical and biological development and research services for third parties; clinical research in the field of hepatic, metabolic, gastrointestinal and oncological diseases and disorders; evaluation of the efficacy of pharmaceutical products; Scientific research in the nature of clinical development services.ACTIVE—
044Advisory services relating to health being medical care; medical information; Providing medical information, namely, compilation of medical reports; medical information services provided via the Internet; medical diagnosis services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 13, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 12, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 23, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 23, 2026FIMPFINAL DISPOSITION PROCESSED—
Dec 2, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 2, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 2, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 15, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 9, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 21, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 19, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 11, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 9, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 20, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 25, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2025DOCKASSIGNED TO EXAMINER—
Feb 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 13, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance